Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme

被引:74
作者
Ciatto, S. [1 ]
Martinelli, F. [1 ]
Castiglione, G. [1 ]
Mantellini, P. [1 ]
Rubeca, T. [1 ]
Grazzini, G. [1 ]
Bonanomi, A. G. [1 ]
Confortini, M. [1 ]
Zappa, M. [1 ]
机构
[1] Ctr Studio & Prevenz Oncol, I-50131 Florence, Italy
关键词
colorectal cancer; faecal occult blood testing; FOBT; screening;
D O I
10.1038/sj.bjc.6603534
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We assessed the correlation between quantitative results of immunological faecal occult blood testing (I-FOBT) and colonic lesions (191 colorectal cancers, 890 adenomas) detected at colonoscopy in 2597 FOBT + (cutoff 100 ng ml(-1) Hb) subjects. At univariate analysis, a higher average faecal Hb content was significantly associated with male gender (P = 0.003), age (P = 0.02), and colonoscopy findings (P = 0.000). Among adenomas, higher faecal Hb content was significantly associated with size (P = 0.0000), presence of severe dysplasia (P = 0.0001), presence of villous component (P = 0.0002), and location in the left colon (P = 0.003). At multivariate analysis adjusting for potential confounders, age (P = 0.03), size (P = 0.0000), and location in the left colon (P = 0.0005) were confirmed as having an independent association with higher faecal Hb content. Immunological FOBT is confirmed to be a specific screening test to detect cancer and adenoma, with a low positivity rate (3.7%) and a high positive predictive value (41.5%). Faecal Hb content is significantly higher for those lesions (cancer and high-risk adenomas) screening is aimed at detecting.
引用
收藏
页码:218 / 221
页数:4
相关论文
共 19 条
  • [1] Advisory Comm Canc Prevention, 2000, EUR J CANCER, V36, P1473
  • [2] Reducing colorectal cancer mortality by repeated faecal occult blood test: a nested case-control study
    Bertario, L
    Russo, A
    Crosignani, P
    Sala, P
    Spinelli, P
    Pizzetti, P
    Andreola, S
    Berrino, F
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (06) : 973 - 977
  • [3] Castiglione G, 1997, J Med Screen, V4, P142
  • [4] Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer
    Castiglione, G
    Zappa, M
    Grazzini, G
    Mazzotta, A
    Biagini, M
    Salvadori, P
    Ciatto, S
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (01) : 141 - 144
  • [5] Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests
    Castiglione, G
    Zappa, M
    Grazzini, G
    Rubeca, T
    Turco, P
    Sani, C
    Ciatto, S
    [J]. JOURNAL OF MEDICAL SCREENING, 2000, 7 (01) : 35 - 37
  • [6] Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood
    Castiglione, G
    Grazzini, G
    Miccinesi, G
    Rubeca, T
    Sani, C
    Turco, P
    Zappa, M
    [J]. JOURNAL OF MEDICAL SCREENING, 2002, 9 (03) : 99 - 103
  • [7] Fecal occult blood screening in the Minnesota study: Role of chance detection of lesions
    Ederer, F
    Church, TR
    Mandel, JS
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (19) : 1423 - 1428
  • [8] Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value
    Edwards, JB
    [J]. PATHOLOGY, 2005, 37 (06) : 565 - U14
  • [9] Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
    Hardcastle, JD
    Chamberlain, JO
    Robinson, MHE
    Moss, SM
    Amar, SS
    Balfour, TW
    James, PD
    Mangham, CM
    [J]. LANCET, 1996, 348 (9040) : 1472 - 1477
  • [10] Randomised study of screening for colorectal cancer with faecal-occult-blood test
    Kronborg, O
    Fenger, C
    Olsen, J
    Jorgensen, OD
    Sondergaard, O
    [J]. LANCET, 1996, 348 (9040) : 1467 - 1471